Skip to content

Clinical trials

Phase 3 Hematologic Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 3 Country / region: South Korea Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20122
20131
20142
20172
20182
20191
20201
20214
20222
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting7
Recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.5
Pfizer3
Genzyme, a Sanofi Company2
Takeda2
Amgen1
Ariad Pharmaceuticals1
BioMarin Pharmaceutical1
Il-Yang Pharm. Co., Ltd.1
Novartis Pharmaceuticals1
Seagen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases21
Bone Marrow Diseases7
Hemorrhagic Disorders6
Lymphoma, Non-Hodgkin6
Lymphoma, B-Cell5
Hemophilia A4
Leukemia4
Leukemia, Lymphocytic, Chronic, B-Cell4
Blood Coagulation Disorders3
Blood Coagulation Disorders, Inherited3

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.